Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("oxaliplatin")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 1448

  • Page / 58
Export

Selection :

  • and

Oxaliplatin-induced neurotoxicity: changes in axonal excitability precede development of neuropathyPARK, Susanna B; LIN, Cindy S.-Y; KRISHNAN, Arun V et al.Brain. 2009, Vol 132, pp 2712-2723, issn 0006-8950, 12 p., 10Article

An immediate hemolytic reaction induced by repeated administration of oxaliplatinCHEN, Vivien M. Y; THRIFT, Karen M; MOREL-KOPP, Marie-Christine et al.Transfusion (Philadelphia, PA). 2004, Vol 44, Num 6, pp 838-843, issn 0041-1132, 6 p.Article

Longitudinal assessment of oxaliplatin-induced neuropathyBURAKGAZI, A. Z; MESSERSMITH, W; VAIDYA, D et al.Neurology. 2011, Vol 77, Num 10, pp 980-986, issn 0028-3878, 7 p.Article

Overcoming oxaliplatin hypersensitivity: different strategies are needed according to the severity and previous exposureLEE, Suh-Young; KANG, Hye-Ryun; SONG, Woo-Jung et al.Cancer chemotherapy and pharmacology. 2014, Vol 73, Num 5, pp 1021-1029, issn 0344-5704, 9 p.Article

5FU and oxaliplatin-containing chemotherapy in two dihydropyrimidine dehydrogenase-deficient patientsREERINK, O; MULDER, N. H; SZABO, B. G et al.Anticancer research. 2004, Vol 24, Num 3B, pp 1969-1971, issn 0250-7005, 3 p.Article

Oxaliplatin-induced immune mediated thrombocytopeniaBEG, Muhammad S; KOMROKJI, Rami S; AHMED, Kashif et al.Cancer chemotherapy and pharmacology. 2008, Vol 62, Num 5, pp 925-927, issn 0344-5704, 3 p.Article

Oxaliplatin-related neurotoxicity : How and why?PASETTO, Lara Maria; D'ANDREA, Mario Rosario; ROSSI, Elena et al.Critical reviews in oncology/hematology. 2006, Vol 59, Num 2, pp 159-168, issn 1040-8428, 10 p.Article

Protection against oxaliplatin-induced mechanical hyperalgesia and intraepidermal nerve fiber loss by minocyclineBOYETTE-DAVIS, J; DOUGHERTY, P. M.Experimental neurology (Print). 2011, Vol 229, Num 2, pp 353-357, issn 0014-4886, 5 p.Article

Acetyl-L-carnitine prevents and reverts experimental chronic neurotoxicity induced by oxaliplatin, without altering its antitumor propertiesGHIRARDI, Orlando; LO GIUDICE, Pietro; ZANNA, Claudio et al.Anticancer research. 2005, Vol 25, Num 4, pp 2681-2687, issn 0250-7005, 7 p.Article

Hypersensitivity reactions to oxaliplatin : experience in a single instituteSIU, S. W. K; CHAN, R. T. T; AU, G. K. H et al.Annals of oncology. 2006, Vol 17, Num 2, pp 259-261, issn 0923-7534, 3 p.Article

Efficacy of IT oxcarbazepine for prophylaxis against cumulative oxaliplatin-induced neuropathyARGYRIOU, A. A; CHRONI, E; POLYCHRONOPOULOS, P et al.Neurology. 2006, Vol 67, Num 12, pp 2253-2255, issn 0028-3878, 3 p.Article

Oxaliplatin-induced immune pancytopeniaTALEGHANI, Behrouz Mansouri; FONTANA, Stefano; MEYER, Oliver et al.Transfusion (Philadelphia, PA). 2005, Vol 45, Num 5, pp 704-708, issn 0041-1132, 5 p.Article

Positive direct and indirect antiglobulin tests associated with oxaliplatin can be due to drug antibody and/or drug-induced nonimmunologic protein adsorptionARNDT, Patricia; GARRATTY, George; ISAAK, Edahn et al.Transfusion (Philadelphia, PA). 2009, Vol 49, Num 4, pp 711-718, issn 0041-1132, 8 p.Article

Oxaliplatin with high-dose leucovorin and infusional 5-fluorouracil in irinotecan-pretreated patients with advanced colorectal cancer (ACC)KOUROUSSIS, Charalambos; SOUGLAKOS, John; GEORGOULIAS, Vassilis et al.American journal of clinical oncology. 2002, Vol 25, Num 6, pp 627-631, issn 0277-3732, 5 p.Article

Clinical Features of Hypersensitivity Reactions to Oxaliplatin : A 10-Year ExperiencePOLYZOS, Aristides; TSAVARIS, Nikolas; NIKITEAS, Nikolas et al.Oncology. 2009, Vol 76, Num 1, pp 36-41, issn 0030-2414, 6 p.Article

Immune-mediated thrombocytopenia resulting from sensitivity to oxaliplatinCURTIS, Brian R; KALISZEWSKI, James; MARQUES, Marisa B et al.American journal of hematology. 2006, Vol 81, Num 3, pp 193-198, issn 0361-8609, 6 p.Article

Oxaliplatin activity in head and neck cancer cell linesESPINOSA, Magali; MARTINEZ, Moises; AGUILAR, José Luis et al.Cancer chemotherapy and pharmacology. 2005, Vol 55, Num 3, pp 301-305, issn 0344-5704, 5 p.Article

Oxaliplatin-associated neuropathy : A reviewCERSOSIMO, Robert J.The Annals of pharmacotherapy. 2005, Vol 39, Num 1, pp 128-135, issn 1060-0280, 8 p.Article

Dose escalation study on oxaliplatin and Capecitabine (Xeloda) in patients with advanced solid tumorsKAKOLYRIS, S; SOUGLAKOS, J; GEORGOULIAS, V et al.Oncology. 2004, Vol 66, Num 4, pp 253-259, issn 0030-2414, 7 p.Article

Randomized phase II study evaluating oxaliplatin alone, oxaliplatin combined with infusional 5-FU, and infusional 5-FU alone in advanced pancreatic carcinoma patientsDUCREUX, M; MITRY, E; MORVAN, F et al.Annals of oncology. 2004, Vol 15, Num 3, pp 467-473, issn 0923-7534, 7 p.Article

Role of the TREK2 potassium channel in cold and warm thermosensation and in pain perceptionPEREIRA, Vanessa; BUSSEROLLES, Jérôme; ESCHALIER, Alain et al.Pain (Amsterdam). 2014, Vol 155, Num 12, pp 2534-2544, issn 0304-3959, 11 p.Article

THE RESPONSE OF SPINAL MICROGLIA TO CHEMOTHERAPY-EVOKED PAINFUL PERIPHERAL NEUROPATHIES IS DISTINCT FROM THAT EVOKED BY TRAUMATIC NERVE INJURIESZHENG, F. Y; XIAO, W.-H; BENNETT, G. J et al.Neuroscience. 2011, Vol 176, pp 447-454, issn 0306-4522, 8 p.Article

Oxaliplatin-induced Pancreatitis: A Case SeriesBUTT, Waseem; SAADATI, Hamid; MUHAMMAD WASIF SAIF et al.Anticancer research. 2010, Vol 30, Num 12, pp 5113-5115, issn 0250-7005, 3 p.Article

Hypersensitivity to Oxaliplatin : An Investigation of Incidence and Risk Factors, and Literature ReviewKIM, Brian H; BRADLEY, Thomas; TAI, Julia et al.Oncology. 2009, Vol 76, Num 4, pp 231-238, issn 0030-2414, 8 p.Article

Analysis of cytotoxicities of platinum compoundsGOODISMAN, Jerry; HAGRMAN, Douglas; TACKA, Kirk A et al.Cancer chemotherapy and pharmacology. 2006, Vol 57, Num 2, pp 257-267, issn 0344-5704, 11 p.Article

  • Page / 58